Special Issue "Antivirals"
A special issue of Molecules (ISSN 1420-3049).
Deadline for manuscript submissions: closed (31 July 2011)
Prof. Dr. Ulrich Jordis (Website)
Institute of Applied Synthetic Chemistry, Vienna University of Technology, Getreidemarkt 9/163, A-1060 Wien, Austria
Fax: +43 1 58801 15499
Interests: antivirals; Alzheimer; quinolones; combinatorial chemistry; labelled compounds; natural products (alkaloids; triterpenes); custom synthesis; chemistry software and databases
Molecules and Pharmaceuticals, being pioneer journals of web-based publications, invites you to submit research articles and comprehensive reviews addressing the discovery and/or development of antiviral agents in animals and man as well as in plants or lower organisms. Despite the tremendous successes and hallmarks e.g. in treating AIDS, clearly there is an ongoing and increased challenge to cope with the evolutionary and constantly changing threats of viral infections that have even the potential to ultra-risks for the mankind. Natural products continue to provide important leads and structures for the development of antiviral compounds and insights into the biochemical pathways and cell live cycles provide new starting points for new antiviral mechanisms. This issue intends to delineate the efforts being made to develop new and effective broad-spectrum antiviral agents e.g. for the treatment of HSV, VZV, HIV, HBV and DNA virus infections.
Prof. Dr. Ulrich Jordis